XORTX Therapeutics XRTX
NASDAQ XRTX
$0.95 -0.04 (-4.30%)
As of: Oct 21, 2026 · 2:59 PM EDT

XORTX Therapeutics (XRTX) Total Debt (2022 - 2026)

Updated

XORTX Therapeutics' Total Debt came in at $61,536 for the quarter ended Mar 31, 2023, down 6.7% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Total Debt (2022 - 2026) Analysis & Trends

As of Dec 31, 2022, XORTX Therapeutics' Total Debt was $68,853.

  • Business Quant data shows XRTX's Total Debt at $65,947 (quarter ended Dec 31, 2022), $67,333 (quarter ended Sep 30, 2022) and $67,556 (quarter ended Jun 30, 2022) in the three quarters before the quarter ended Mar 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn 70.82 Bn
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn 63.19 Bn
10 XORTX Therapeutics 898,160.24 -2.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -15,056.00
Dec 31, 2025 -37,287.00
Sep 30, 2025 -59,094.00
Mar 31, 2025 -15,662.00
Dec 31, 2023 -8,700.19
Mar 31, 2023 61,536.00
Dec 31, 2022 66,054.45
Sep 30, 2022 64,219.53
Jun 30, 2022 66,854.77
API Access

XORTX Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=XRTX&period=max&api_key=YOUR_API_KEY